Early Rhythm Control for Device-Detected Fast Heart Episodes
Part of Heart & circulation clinical trials.
This trial tests whether starting treatment early to control your heart's rhythm can help people with a heart device who have short bursts of a fast heartbeat (called atrial high rate episodes) but haven't yet been diagnosed with atrial fibrillation on a standard EKG or Holter monitor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a heart device (like a pacemaker, ICD, or loop recorder) that can detect fast heart rhythms from the upper chambers.
- In the last 3 months, your device must have recorded fast heart episodes that added up to more than 21 hours.
- You must not have had a standard EKG or Holter monitor show atrial fibrillation (AFib) in the past year (though a very short episode under 30 seconds is okay).
- You should not be taking certain heart rhythm medications (called Class Ic or III antiarrhythmics) right now.
- You must have a life expectancy of more than one year and not be in hospice or unable to get a heart transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different heart rate targets for people with ongoing atrial fibrillation (an irregular heartbeat) to find which one improves symptoms and quality of life. It may help you and your doctor choose the best treatment plan.
This trial tests whether a procedure called electrical cardioversion (a controlled shock to reset your heart rhythm) can help explain and possibly improve symptoms of atrial fibrillation and heart failure. If you qualify, you'll receive this procedure and your symptoms will be closely monitored.
This study follows patients getting a newer heart rhythm treatment called pulsed field ablation for atrial fibrillation (an irregular heartbeat). Researchers want to understand which patients do well long-term and which may need additional treatment.
This study follows patients who have a heart rhythm device (pacemaker, defibrillator, or resynchronization device) and have experienced brief episodes of fast irregular heartbeats detected by the device. The study compares treatment approaches to understand which helps patients stay healthier and feel better.
This trial tests an early treatment approach for people who had a recent ischemic stroke (a stroke caused by a blocked blood vessel) and have an irregular heart rhythm called atrial fibrillation (AF). It aims to lower the chance of having another stroke by treating AF as early as possible after the stroke.
This study looks at whether a “rate control” or “rhythm control” approach works better for people with CRT devices who still have atrial fibrillation. It aims to improve heart failure symptoms and help the heart pace more effectively.
Hear when a new Diseases of the Circulatory System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.